Submitted by Anonymous (not verified) on 31 August 2023 - 9:43
Opinion/decision on a Paediatric investigation plan (PIP): Ronapreve,Casirivimab, decision type: , therapeutic area: , PIP number: P/0300/2022
Source:
Opinion/decision on a Paediatric investigation plan (PIP): Ronapreve,Casirivimab, decision type: , therapeutic area: , PIP number: P/0300/2022